{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:24:31Z","timestamp":1794464671379,"version":"4.9.1"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07873-0","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:55:35Z","timestamp":1771671335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Decoding myeloid heterogeneity in glioblastoma: spatial insights from transcriptomics"],"prefix":"10.1186","volume":"24","author":[{"given":"Yilun","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9682-4183","authenticated-orcid":false,"given":"Jianyang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"7873_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13059-017-1362-4","volume":"18","author":"S M\u00fcller","year":"2017","unstructured":"M\u00fcller S, et al. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Genome Biol. 2017;18:234. https:\/\/doi.org\/10.1186\/s13059-017-1362-4.","journal-title":"Genome Biol"},{"key":"7873_CR2","doi-asserted-by":"publisher","unstructured":"D B, Jd L. Cancer stem cell-immune cell crosstalk in tumour progression - PubMed. Nat Rev Cancer. 2021, Aug;21. https:\/\/doi.org\/10.1038\/s41568-021-00366-w.","DOI":"10.1038\/s41568-021-00366-w"},{"key":"7873_CR3","doi-asserted-by":"publisher","unstructured":"S L, J C-C, E H, Ap C, Ss M. New insights into the multifaceted Role of myeloid-derived suppressor cells (MDSCs) in high-grade gliomas: from metabolic reprograming, immunosuppression, and therapeutic resistance to current strategies for targeting MDSCs - PubMed. Cells. 10. 04\/14\/2021https:\/\/doi.org\/10.3390\/cells10040893.","DOI":"10.3390\/cells10040893"},{"key":"7873_CR4","doi-asserted-by":"publisher","unstructured":"J V, C S-F, Cm S. Dendritic cells in the tumor microenvironment: prognostic and theranostic impact - PubMed. Semin Immunol. 2020 Apr;48. https:\/\/doi.org\/10.1016\/j.smim.2020.101410.","DOI":"10.1016\/j.smim.2020.101410"},{"key":"7873_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","volume":"24","author":"AR Pombo Antunes","year":"2021","unstructured":"Pombo Antunes AR, et al. Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Nat Neurosci. 2021;24:595\u2013610. https:\/\/doi.org\/10.1038\/s41593-020-00789-y.","journal-title":"Nat Neurosci"},{"key":"7873_CR6","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1038\/s41388-021-02010-1","volume":"40","author":"Z Ye","year":"2021","unstructured":"Ye Z, et al. Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics. Oncogene. 2021;40:6059\u201370. https:\/\/doi.org\/10.1038\/s41388-021-02010-1.","journal-title":"Oncogene"},{"key":"7873_CR7","doi-asserted-by":"publisher","unstructured":"Bl M, et al. Impact of epigenetic reprogramming on antitumor immune responses in glioma - PubMed. J Clin Investigation. 133. 01\/17\/2023. https:\/\/doi.org\/10.1172\/JCI163450.","DOI":"10.1172\/JCI163450"},{"key":"7873_CR8","doi-asserted-by":"publisher","unstructured":"M SP, et al. Myeloid-derived suppressor cells (MDSCs) in brain cancer: challenges and therapeutic strategies - PubMed. Inflammopharmacology. 2021 Dec;29. https:\/\/doi.org\/10.1007\/s10787-021-00878-9.","DOI":"10.1007\/s10787-021-00878-9"},{"key":"7873_CR9","doi-asserted-by":"publisher","unstructured":"Haley MJ, et al. Hypoxia coordinates the spatial landscape of myeloid cells within glioblastoma to affect survival. Sci Adv. 2024;10:eadj3301. https:\/\/doi.org\/10.1126\/sciadv.adj3301.","DOI":"10.1126\/sciadv.adj3301"},{"key":"7873_CR10","doi-asserted-by":"publisher","unstructured":"A S, et al. Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression - PubMed. Immunity. 56. 08\/8\/2023. https:\/\/doi.org\/10.1016\/j.immuni.2023.06.017.","DOI":"10.1016\/j.immuni.2023.06.017"},{"key":"7873_CR11","doi-asserted-by":"publisher","first-page":"1475235","DOI":"10.3389\/fimmu.2024.1475235","volume":"15","author":"L Cao","year":"2024","unstructured":"Cao L, Lu X, Wang X, Wu H, Miao X. From single-cell to spatial transcriptomics: decoding the glioma stem cell niche and its clinical implications. Front Immunol. 2024;15:1475235. https:\/\/doi.org\/10.3389\/fimmu.2024.1475235.","journal-title":"Front Immunol"},{"key":"7873_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s40478-024-01837-5","volume":"12","author":"M Motevasseli","year":"2024","unstructured":"Motevasseli M, et al. Distinct tumor-TAM interactions in IDH-stratified glioma microenvironments unveiled by single-cell and spatial transcriptomics. Acta Neuropathol Commun. 2024;12:133. https:\/\/doi.org\/10.1186\/s40478-024-01837-5.","journal-title":"Acta Neuropathol Commun"},{"key":"7873_CR13","doi-asserted-by":"publisher","unstructured":"Vm R, et al. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma - PubMed. Cancer Cell. 40. 06\/13\/2022. https:\/\/doi.org\/10.1016\/j.ccell.2022.05.009.","DOI":"10.1016\/j.ccell.2022.05.009"},{"key":"7873_CR14","doi-asserted-by":"publisher","unstructured":"S K, J Y, B L, X F. Causal Association between immune cell traits and risk of multiple malignant and nonmalignant CNS Diseases: a Mendelian randomization and single-cell transcriptomic analysis - PubMed. Brain Behav. 2025, Aug;15. https:\/\/doi.org\/10.1002\/brb3.70632.","DOI":"10.1002\/brb3.70632"},{"key":"7873_CR15","doi-asserted-by":"publisher","unstructured":"Db B, et al. Quantifying the effect of experimental perturbations at single-cell resolution - PubMed. Nat Biotechnol. 2021 May;39. https:\/\/doi.org\/10.1038\/s41587-020-00803-5.","DOI":"10.1038\/s41587-020-00803-5"},{"key":"7873_CR16","doi-asserted-by":"publisher","unstructured":"Ma IG, \u00c1 L-J, A LA, I A-I, F G-G. A quantitative digital analysis of tissue immune components reveals an immunosuppressive and anergic immune response with relevant prognostic significance in glioblastoma - PubMed. Biomedicines. 10. 07\/21\/2022. https:\/\/doi.org\/10.3390\/biomedicines10071753.","DOI":"10.3390\/biomedicines10071753"},{"key":"7873_CR17","doi-asserted-by":"publisher","unstructured":"M T, et al. A review of emerging immunotherapeutic strategies for IDH-Mutant glioma - PubMed. Cancers. 17. 06\/27\/2025. https:\/\/doi.org\/10.3390\/cancers17132178.","DOI":"10.3390\/cancers17132178"},{"key":"7873_CR18","doi-asserted-by":"publisher","unstructured":"Ep G, et al. Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma - PubMed. Clin Cancer Res: Off J Am Assoc Cancer Res. 30. 09\/13\/2024. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-1056.","DOI":"10.1158\/1078-0432.CCR-24-1056"},{"key":"7873_CR19","doi-asserted-by":"publisher","unstructured":"S P, et al. Diverse facets of MDSC in different phases of chronic HBV infection: impact on HBV-specific T-cell response and homing - PubMed. Hepatol (Baltim, Md.). 2022 Sep;76. https:\/\/doi.org\/10.1002\/hep.32331.","DOI":"10.1002\/hep.32331"},{"key":"7873_CR20","doi-asserted-by":"publisher","unstructured":"L K, et al. A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging - PubMed. Cell. 174. 09\/6\/2018. https:\/\/doi.org\/10.1016\/j.cell.2018.08.039.","DOI":"10.1016\/j.cell.2018.08.039"},{"key":"7873_CR21","doi-asserted-by":"publisher","unstructured":"G M, V LC, M G, G G, S C. Artificial intelligence-driven multi-omics approaches in glioblastoma - PubMed. Int J Mol Sci. 26. 09\/25\/2025. https:\/\/doi.org\/10.3390\/ijms26199362.","DOI":"10.3390\/ijms26199362"},{"key":"7873_CR22","doi-asserted-by":"publisher","unstructured":"Z C, et al. Cellular and molecular identity of tumor-associated macrophages in glioblastoma - PubMed. Cancer Res. 77. 05\/1\/2017. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2310.","DOI":"10.1158\/0008-5472.CAN-16-2310"},{"key":"7873_CR23","doi-asserted-by":"publisher","unstructured":"S B, Ka H, N R, Ss G, Aj T. Single-cell analysis reveals diversity of tumor-associated macrophages and their interactions with T lymphocytes in glioblastoma - PubMed. Sci Rep. 13. 11\/27\/2023. https:\/\/doi.org\/10.1038\/s41598-023-48116-2.","DOI":"10.1038\/s41598-023-48116-2"},{"key":"7873_CR24","doi-asserted-by":"publisher","unstructured":"X L, W G, X L, M W. New insights into monocyte-derived macrophages in glioblastoma - PubMed. Res (Wash, D.C. (8). 08\/12\/2025. https:\/\/doi.org\/10.34133\/research.0836.","DOI":"10.34133\/research.0836"},{"key":"7873_CR25","doi-asserted-by":"publisher","unstructured":"Me C, et al. Tumor progression is independent of tumor-associated macrophages in cell lineage-based mouse models of glioblastoma - PubMed. Proceedings of the National Academy of Sciences of the United States of America, 120. 04\/18\/2023. https:\/\/doi.org\/10.1073\/pnas.2222084120.","DOI":"10.1073\/pnas.2222084120"},{"key":"7873_CR26","doi-asserted-by":"publisher","unstructured":"F K, et al. Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells - PubMed. Cell. 2020;181. https:\/\/doi.org\/10.1016\/j.cell.2020.05.007.","DOI":"10.1016\/j.cell.2020.05.007"},{"key":"7873_CR27","doi-asserted-by":"publisher","unstructured":"N O, et al. Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages - PubMed. Nat Commun. 2021;12. https:\/\/doi.org\/10.1038\/s41467-021-21407-w.","DOI":"10.1038\/s41467-021-21407-w"},{"key":"7873_CR28","doi-asserted-by":"publisher","unstructured":"Y G, D C, Q J, H X, J Z. Mechanisms underlying the Role of myeloid-derived suppressor cells in clinical Diseases: good or bad - PubMed. Immune Network. 21. 05\/26\/2021. https:\/\/doi.org\/10.4110\/in.2021.21.e21.","DOI":"10.4110\/in.2021.21.e21"},{"key":"7873_CR29","doi-asserted-by":"publisher","unstructured":"X G, et al. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a\/Rora and miR-21\/Pten pathways - PubMed. Oncogene. 2018, Aug;37. https:\/\/doi.org\/10.1038\/s41388-018-0261-9.","DOI":"10.1038\/s41388-018-0261-9"},{"key":"7873_CR30","doi-asserted-by":"publisher","unstructured":"F K, et al. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy - PubMed. J Clin Investigation. 133. 01\/3\/2023. https:\/\/doi.org\/10.1172\/JCI163446.","DOI":"10.1172\/JCI163446"},{"key":"7873_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3892\/or.2014.3214","volume":"32","author":"K Hattermann","year":"2014","unstructured":"Hattermann K, et al. Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages\/microglia. Oncol Rep. 2014;32:270\u201376. https:\/\/doi.org\/10.3892\/or.2014.3214.","journal-title":"Oncol Rep"},{"key":"7873_CR32","doi-asserted-by":"publisher","unstructured":"X G, R S, H P. Tumor-derived small extracellular vesicles: potential roles and mechanism in glioma - PubMed. J Nanobiotechnol. 20. 08\/23\/2022. https:\/\/doi.org\/10.1186\/s12951-022-01584-6.","DOI":"10.1186\/s12951-022-01584-6"},{"key":"7873_CR33","doi-asserted-by":"publisher","unstructured":"R S, et al. Mapping microglia states in the human brain through the integration of high-dimensional techniques - PubMed. Nat Neurosci. 2019 Dec;22. https:\/\/doi.org\/10.1038\/s41593-019-0532-y.","DOI":"10.1038\/s41593-019-0532-y"},{"key":"7873_CR34","doi-asserted-by":"publisher","unstructured":"S G, et al. Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma - PubMed. Sci Transl Med. 15. 01\/25\/2023. https:\/\/doi.org\/10.1126\/scitranslmed.abn6758.","DOI":"10.1126\/scitranslmed.abn6758"},{"key":"7873_CR35","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","volume":"4","author":"Y Mei","year":"2023","unstructured":"Mei Y, et al. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. Nat Cancer. 2023;4:1273\u201391. https:\/\/doi.org\/10.1038\/s43018-023-00598-9.","journal-title":"Nat Cancer"},{"key":"7873_CR36","doi-asserted-by":"publisher","unstructured":"L P, F Z, P C. Lipid-laden macrophages recycle myelin to feed glioblastoma - PubMed. Cancer Res. 2024;84. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-3362.","DOI":"10.1158\/0008-5472.CAN-24-3362"},{"key":"7873_CR37","doi-asserted-by":"publisher","unstructured":"S R, et al. Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma - PubMed. Cell Rep. 2023;42. https:\/\/doi.org\/10.1016\/j.celrep.2023.112197.","DOI":"10.1016\/j.celrep.2023.112197"},{"key":"7873_CR38","doi-asserted-by":"publisher","unstructured":"Ruiz-Moreno C, et al. Harmonized single-cell landscape, intercellular crosstalk and tumor architecture of glioblastoma. bioRxiv. 2022;2022:2008.2027.505439. https:\/\/doi.org\/10.1101\/2022.08.27.505439.","DOI":"10.1101\/2022.08.27.505439"},{"key":"7873_CR39","doi-asserted-by":"publisher","unstructured":"Coy S, et al. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. Nat Commun. 2022;13:1(13):2022\u201308\u201316. https:\/\/doi.org\/10.1038\/s41467-022-32430-w.","DOI":"10.1038\/s41467-022-32430-w"},{"key":"7873_CR40","doi-asserted-by":"publisher","unstructured":"K B, et al. Distinct spatiotemporal features of microglia and monocyte-derived macrophages in glioma - PubMed. Eur J Immunol. 2023 Apr;53. https:\/\/doi.org\/10.1002\/eji.202250161.","DOI":"10.1002\/eji.202250161"},{"key":"7873_CR41","doi-asserted-by":"publisher","unstructured":"S M, Mhh S, U S. The glioma immune landscape: a Double-edged sword for treatment regimens - PubMed. Cancers. 15. 03\/28\/2023. https:\/\/doi.org\/10.3390\/cancers15072024.","DOI":"10.3390\/cancers15072024"},{"key":"7873_CR42","doi-asserted-by":"publisher","unstructured":"Z L, et al. Single-cell and spatial analyses reveal the effect of VSIG4+S100A10+TAMs on the immunosuppression of glioblastoma and anti-PD-1 immunotherapy - PubMed. Int J Biol Macromolecules. 2025 May;308. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142415.","DOI":"10.1016\/j.ijbiomac.2025.142415"},{"key":"7873_CR43","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41467-022-28523-1","volume":"13","author":"VM Ravi","year":"2022","unstructured":"Ravi VM, et al. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun. 2022;13:925. https:\/\/doi.org\/10.1038\/s41467-022-28523-1.","journal-title":"Nat Commun"},{"issue":"8060","key":"7873_CR44","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41586-025-08633-8","volume":"640","author":"TE Miller","year":"2025","unstructured":"Miller TE, et al. Programs, origins and immunomodulatory functions of myeloid cells in glioma. Nature. 2025;640(8060):640. 2025-02-26. https:\/\/doi.org\/10.1038\/s41586-025-08633-8.","journal-title":"Nature"},{"key":"7873_CR45","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","volume":"42","author":"W Wang","year":"2024","unstructured":"Wang W, et al. Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. Cancer Cell. 2024;42:815\u201332.e812. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.013.","journal-title":"Cancer Cell"},{"key":"7873_CR46","doi-asserted-by":"publisher","unstructured":"Tang J, Karbhari N, Campian JL. Therapeutic targets in glioblastoma: molecular pathways, emerging strategies, and future directions. Cells. 2025 Mar, 26;14. https:\/\/doi.org\/10.3390\/cells14070494.","DOI":"10.3390\/cells14070494"},{"key":"7873_CR47","doi-asserted-by":"publisher","unstructured":"Jain KK. A critical overview of targeted therapies for glioblastoma. Front Oncol. 2018 Oct 15;8. https:\/\/doi.org\/10.3389\/fonc.2018.00419.","DOI":"10.3389\/fonc.2018.00419"},{"key":"7873_CR48","doi-asserted-by":"publisher","unstructured":"E A, et al. Tumor microenvironment and glioblastoma cell interplay as promoters of therapeutic resistance - PubMed. Biology. 12. 05\/18\/2023. https:\/\/doi.org\/10.3390\/biology12050736.","DOI":"10.3390\/biology12050736"},{"key":"7873_CR49","doi-asserted-by":"publisher","unstructured":"Dk T, Lp P, S B, K B. Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches - PubMed. Front Pharmacol. 15. 03\/8\/2024. https:\/\/doi.org\/10.3389\/fphar.2024.1355242.","DOI":"10.3389\/fphar.2024.1355242"},{"key":"7873_CR50","doi-asserted-by":"publisher","unstructured":"Aj Y, S R. Molecular targets for combined therapeutic strategies to limit glioblastoma cell migration and invasion - PubMed. Front Pharmacol. 11. 03\/27\/2020. https:\/\/doi.org\/10.3389\/fphar.2020.00358.","DOI":"10.3389\/fphar.2020.00358"},{"key":"7873_CR51","doi-asserted-by":"publisher","unstructured":"G Y, et al. Glioblastoma exploits ATP from leading-edge astrocytes to fuel its infiltrative growth revealed by spatially resolved chimeric analysis - PubMed. Sci Adv. 11. 09\/26\/2025. https:\/\/doi.org\/10.1126\/sciadv.adv5673.","DOI":"10.1126\/sciadv.adv5673"},{"key":"7873_CR52","doi-asserted-by":"publisher","unstructured":"Ai CB, et al. Metabolic reprogramming in glioblastoma multiforme: a review of pathways and therapeutic targets - PubMed. Cells. 13. 09\/19\/2024. https:\/\/doi.org\/10.3390\/cells13181574.","DOI":"10.3390\/cells13181574"},{"key":"7873_CR53","doi-asserted-by":"publisher","unstructured":"Ayuso JM, et al. Glioblastoma on a microfluidic chip: generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events. Neuro-Oncology. 2017\/04\/01;19. https:\/\/doi.org\/10.1093\/neuonc\/now230.","DOI":"10.1093\/neuonc\/now230"},{"key":"7873_CR54","doi-asserted-by":"publisher","unstructured":"Kim Y, et al. Translational mRNA profiling analysis of pseudopalisading cells in bevacizumab resistance of GBM. Adv Ther. 2023\/11\/01;6. https:\/\/doi.org\/10.1002\/adtp.202300148.","DOI":"10.1002\/adtp.202300148"},{"key":"7873_CR55","doi-asserted-by":"publisher","unstructured":"M H, Y L, J P, Y C. Causal effects of immune cells in glioblastoma: a Bayesian Mendelian randomization study - PubMed. Front Neurol. 15. 04\/29\/2024. https:\/\/doi.org\/10.3389\/fneur.2024.1375723.","DOI":"10.3389\/fneur.2024.1375723"},{"key":"7873_CR56","doi-asserted-by":"publisher","unstructured":"Tj A, et al. Glioblastoma myeloid-derived suppressor cell subsets express differential macrophage migration Inhibitory Factor receptor profiles that can Be targeted to reduce immune suppression - PubMed. Front Immunol. 11. 06\/18\/2020. https:\/\/doi.org\/10.3389\/fimmu.2020.01191.","DOI":"10.3389\/fimmu.2020.01191"},{"key":"7873_CR57","doi-asserted-by":"publisher","unstructured":"A R, et al. Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth - PubMed. Cell Metab. 36. 01\/2\/2024. https:\/\/doi.org\/10.1016\/j.cmet.2023.11.013.","DOI":"10.1016\/j.cmet.2023.11.013"},{"key":"7873_CR58","doi-asserted-by":"publisher","unstructured":"Schupper AJ, Hadjipanayis CG. Novel approaches to targeting gliomas at the leading\/cutting edge. J Neurosurg. 2023 Feb 24;139. https:\/\/doi.org\/10.3171\/2023.1.JNS221798.","DOI":"10.3171\/2023.1.JNS221798"},{"key":"7873_CR59","doi-asserted-by":"publisher","unstructured":"R S, M D, H Z, X L, B H. Tumor niches: perspectives for targeted therapies in glioblastoma - PubMed. Antioxid Redox Signaling. 2023 Nov;39. https:\/\/doi.org\/10.1089\/ars.2022.0187.","DOI":"10.1089\/ars.2022.0187"},{"key":"7873_CR60","doi-asserted-by":"publisher","unstructured":"H L, et al. Therapeutic strategies of glioblastoma (GBM): the current advances in the molecular targets and bioactive small molecule compounds - PubMed. Acta Pharmaceutica Sin. B. 2022 Apr;12. https:\/\/doi.org\/10.1016\/j.apsb.2021.12.019.","DOI":"10.1016\/j.apsb.2021.12.019"},{"key":"7873_CR61","doi-asserted-by":"publisher","unstructured":"A T, et al. Glioblastoma: current status, emerging targets, and Recent advances - PubMed. J Med Chem. 65. 07\/14\/2022. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01946.","DOI":"10.1021\/acs.jmedchem.1c01946"},{"key":"7873_CR62","doi-asserted-by":"publisher","unstructured":"Yy X, P G, Y S, Yr D. Development of targeted therapies in treatment of glioblastoma - PubMed. Cancer Biol Med. 2015 Sep;12. https:\/\/doi.org\/10.7497\/j.issn.2095-3941.2015.0020.","DOI":"10.7497\/j.issn.2095-3941.2015.0020"},{"key":"7873_CR63","doi-asserted-by":"publisher","unstructured":"W G, et al. Targeting mesenchymal monocyte-derived macrophages to enhance the sensitivity of glioblastoma to temozolomide by inhibiting TNF\/CELSR2\/p65\/Kla-HDAC1\/EPAS1 axis - PubMed. J Adv Res. 05\/13\/2025. https:\/\/doi.org\/10.1016\/j.jare.2025.05.032.","DOI":"10.1016\/j.jare.2025.05.032"},{"key":"7873_CR64","doi-asserted-by":"publisher","unstructured":"Sk W, et al. Dendritic cells in cancer immunology and immunotherapy - PubMed. Nat Rev. Immunol. 2020, Jan;20. https:\/\/doi.org\/10.1038\/s41577-019-0210-z.","DOI":"10.1038\/s41577-019-0210-z"},{"key":"7873_CR65","doi-asserted-by":"publisher","unstructured":"J Z, et al. Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection - PubMed. Nat Nanotechnol. 2021 May;16. https:\/\/doi.org\/10.1038\/s41565-020-00843-7.","DOI":"10.1038\/s41565-020-00843-7"},{"key":"7873_CR66","doi-asserted-by":"publisher","unstructured":"Ki L, et al. Bavituximab decreases immunosuppressive myeloid-derived suppressor cells in newly diagnosed glioblastoma patients - PubMed. Clin Cancer Res: Off J Am Assoc Cancer Res. 2023;29. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0203.","DOI":"10.1158\/1078-0432.CCR-23-0203"},{"key":"7873_CR67","doi-asserted-by":"publisher","unstructured":"Pandey S, et al. Frontiers in glioblastoma therapy: novel therapeutics, molecular pathways, and future clinical perspectives. Hum Gene. 2026\/02\/01;47. https:\/\/doi.org\/10.1016\/j.humgen.2025.201507.","DOI":"10.1016\/j.humgen.2025.201507"},{"key":"7873_CR68","doi-asserted-by":"publisher","unstructured":"N DI, S M, S P. Altered metabolism in glioblastoma: myeloid-derived suppressor cell (MDSC) fitness and tumor-infiltrating Lymphocyte (TIL) dysfunction - PubMed. Int J Mol Sci. 22. 04\/24\/2021. https:\/\/doi.org\/10.3390\/ijms22094460.","DOI":"10.3390\/ijms22094460"},{"key":"7873_CR69","doi-asserted-by":"publisher","unstructured":"Al C, et al. CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells - PubMed. Cancer Res. 2016;76. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0144.","DOI":"10.1158\/0008-5472.CAN-16-0144"},{"key":"7873_CR70","doi-asserted-by":"publisher","unstructured":"D G, O R, MC A-G, F P, C P-G-S. Like cells, metabolic strategy to kill a challenging target - PubMed. Front Oncol. 9. 03\/6\/2019. https:\/\/doi.org\/10.3389\/fonc.2019.00118.","DOI":"10.3389\/fonc.2019.00118"},{"key":"7873_CR71","doi-asserted-by":"publisher","unstructured":"S K, et al. Role of neutrophils and myeloid-derived suppressor cells in glioma progression and treatment resistance - PubMed. Int J Mol Sci. 21. 03\/13\/2020. https:\/\/doi.org\/10.3390\/ijms21061954.","DOI":"10.3390\/ijms21061954"},{"key":"7873_CR72","doi-asserted-by":"publisher","unstructured":"A DL, A U, F V. Myeloid cells in glioblastoma microenvironment - PubMed. Cells. 10. 12\/24\/2020. https:\/\/doi.org\/10.3390\/cells10010018.","DOI":"10.3390\/cells10010018"},{"key":"7873_CR73","doi-asserted-by":"publisher","unstructured":"M P, et al. Mechanisms regulating transitory suppressive activity of neutrophils in newborns: PMNs-MDSCs in newborns - PubMed. J Leukocyte Biol. 2022 Nov;112. https:\/\/doi.org\/10.1002\/JLB.4HI0921-514RR.","DOI":"10.1002\/JLB.4HI0921-514RR"},{"key":"7873_CR74","doi-asserted-by":"publisher","unstructured":"Y W, M Y, M N, Q M, K W. Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy - PubMed. Mol Cancer. 21. 09\/26\/2022. https:\/\/doi.org\/10.1186\/s12943-022-01657-y.","DOI":"10.1186\/s12943-022-01657-y"},{"key":"7873_CR75","doi-asserted-by":"publisher","unstructured":"Kcm S, et al. Expression profiling of immune inhibitory siglecs and their ligands in patients with glioma - PubMed. Cancer Immunol, Immunother: CII. 2019, Jun;68. https:\/\/doi.org\/10.1007\/s00262-019-02332-w.","DOI":"10.1007\/s00262-019-02332-w"},{"key":"7873_CR76","doi-asserted-by":"publisher","unstructured":"Y Z, L G, M S, X L. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment - PubMed. Cancer Biol Med. 17. 02\/15\/2020. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2019.0372.","DOI":"10.20892\/j.issn.2095-3941.2019.0372"},{"key":"7873_CR77","doi-asserted-by":"publisher","unstructured":"D G, et al. Neutrophils as potential therapeutic targets in hepatocellular carcinoma - PubMed. Nat Rev. Gastroenterol Hepatol. 2022 Apr;19. https:\/\/doi.org\/10.1038\/s41575-021-00568-5.","DOI":"10.1038\/s41575-021-00568-5"},{"key":"7873_CR78","doi-asserted-by":"publisher","unstructured":"Ca L, et al. Hallmarks of the tumour microenvironment of gliomas and its interaction with emerging immunotherapy modalities - PubMed. Int J Mol Sci. 24. 08\/25\/2023. https:\/\/doi.org\/10.3390\/ijms241713215.","DOI":"10.3390\/ijms241713215"},{"key":"7873_CR79","doi-asserted-by":"publisher","unstructured":"Jackson C, et al. Distinct myeloid-derived suppressor cell populations in human glioblastoma. Science. 2025;387:eabm5214. https:\/\/doi.org\/10.1126\/science.abm5214.","DOI":"10.1126\/science.abm5214"},{"key":"7873_CR80","doi-asserted-by":"publisher","unstructured":"B O, et al. Cancer stem cell-Secreted macrophage migration Inhibitory Factor stimulates myeloid derived suppressor cell function and facilitates glioblastoma immune evasion - PubMed. STEM Cells (Dayt, Ohio). 2016 Aug;34. https:\/\/doi.org\/10.1002\/stem.2393.","DOI":"10.1002\/stem.2393"},{"key":"7873_CR81","doi-asserted-by":"publisher","unstructured":"D B, et al. Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner - PubMed. Cancer Discov. 2020 Aug;10. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1355.","DOI":"10.1158\/2159-8290.CD-19-1355"},{"key":"7873_CR82","doi-asserted-by":"publisher","unstructured":"At Y, et al. Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression - PubMed. Nat Immunol. 2022 Jun;23. https:\/\/doi.org\/10.1038\/s41590-022-01215-0.","DOI":"10.1038\/s41590-022-01215-0"},{"key":"7873_CR83","doi-asserted-by":"publisher","unstructured":"P DB, et al. Myeloid diagnostic and prognostic markers of immune suppression in the blood of glioma patients - PubMed. Front Immunol. 2022;12. https:\/\/doi.org\/10.3389\/fimmu.2021.809826.","DOI":"10.3389\/fimmu.2021.809826"},{"key":"7873_CR84","doi-asserted-by":"publisher","unstructured":"Qt O, et al. CBTRUS statistical report: primary brain and other central nervous System tumors Diagnosed in the United States in 2015\u20132019 - PubMed. Neuro-Oncology. 24. 10\/5\/2022. https:\/\/doi.org\/10.1093\/neuonc\/noac202.","DOI":"10.1093\/neuonc\/noac202"},{"key":"7873_CR85","doi-asserted-by":"publisher","unstructured":"W Y, et al. Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data - PubMed. Sci Transl Med. 11. 01\/2\/2019. https:\/\/doi.org\/10.1126\/scitranslmed.aao5253.","DOI":"10.1126\/scitranslmed.aao5253"},{"key":"7873_CR86","doi-asserted-by":"publisher","unstructured":"Pr G, et al. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8\/9 and arginase and suppress T cell function - PubMed. Neuro-Oncology. 2016 Sep;18. https:\/\/doi.org\/10.1093\/neuonc\/now034.","DOI":"10.1093\/neuonc\/now034"},{"key":"7873_CR87","doi-asserted-by":"publisher","unstructured":"E C, L Z, C L. LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression - PubMed. Cancer Manag Res. 2019;11. https:\/\/doi.org\/10.2147\/CMAR.S210545.","DOI":"10.2147\/CMAR.S210545"},{"key":"7873_CR88","doi-asserted-by":"publisher","unstructured":"H L, et al. Host STING-dependent MDSC mobilization drives extrinsic radiation resistance - PubMed. Nat Commun. 2017;8. https:\/\/doi.org\/10.1038\/s41467-017-01566-5.","DOI":"10.1038\/s41467-017-01566-5"},{"key":"7873_CR89","doi-asserted-by":"publisher","unstructured":"V B, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards - PubMed. Nat Commun. 7. 07\/6\/2016. https:\/\/doi.org\/10.1038\/ncomms12150.","DOI":"10.1038\/ncomms12150"},{"key":"7873_CR90","doi-asserted-by":"publisher","unstructured":"V K, S P, E T, DI G. The Nature of myeloid-derived suppressor cells in the tumor microenvironment - PubMed. Trends Immunol. 2016 Mar;37. https:\/\/doi.org\/10.1016\/j.it.2016.01.004.","DOI":"10.1016\/j.it.2016.01.004"},{"key":"7873_CR91","doi-asserted-by":"publisher","unstructured":"F V, DI G. Dendritic cells in cancer: the role revisited - PubMed. Curr Opin Immunol. 2017 Apr;45. https:\/\/doi.org\/10.1016\/j.coi.2017.01.002.","DOI":"10.1016\/j.coi.2017.01.002"},{"key":"7873_CR92","doi-asserted-by":"publisher","unstructured":"Cs N, et al. The granulocyte progenitor stage is a Key target of IRF8-mediated regulation of myeloid-derived suppressor cell production - PubMed. In: Journal of immunology. Vol. 198. (Baltimore, Md; 1950). 05\/15\/2017). https:\/\/doi.org\/10.4049\/jimmunol.1601722.","DOI":"10.4049\/jimmunol.1601722"},{"key":"7873_CR93","doi-asserted-by":"publisher","unstructured":"D E, Ya W. Glioblastoma heterogeneity at single cell resolution - PubMed. Oncogene. 2023 Jun;42. https:\/\/doi.org\/10.1038\/s41388-023-02738-y.","DOI":"10.1038\/s41388-023-02738-y"},{"key":"7873_CR94","doi-asserted-by":"publisher","unstructured":"Kmb B, et al. Radiation therapy and myeloid-derived suppressor cells: breaking down their cancerous partnership - PubMed. Int J Radiat Oncol, Biol, Phys. 119. 05\/1\/2024. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.11.050.","DOI":"10.1016\/j.ijrobp.2023.11.050"},{"key":"7873_CR95","doi-asserted-by":"publisher","unstructured":"E K, et al. Single-cell spatial immune landscapes of primary and metastatic brain tumours - PubMed. Nature. 2023 Feb;614. https:\/\/doi.org\/10.1038\/s41586-022-05680-3.","DOI":"10.1038\/s41586-022-05680-3"},{"key":"7873_CR96","doi-asserted-by":"publisher","unstructured":"K A, et al. Dendritic cells trigger IFN-\u03b3 secretion by NK cells independent of IL-12 and IL-18 - PubMed. Eur J Immunol. 2022 Sep;52. https:\/\/doi.org\/10.1002\/eji.202149733.","DOI":"10.1002\/eji.202149733"},{"key":"7873_CR97","doi-asserted-by":"publisher","unstructured":"X H, C J, Y G, X X. Human dendritic cell subsets in the glioblastoma-associated microenvironment - PubMed. J Neuroimmunol. 383. 10\/15\/2023. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578147.","DOI":"10.1016\/j.jneuroim.2023.578147"},{"key":"7873_CR98","doi-asserted-by":"publisher","unstructured":"L Z, et al. CCL21 Induces Plasmacytoid Dendritic cell migration and activation in a mouse model of glioblastoma - PubMed. Cancers. 2024;16. https:\/\/doi.org\/10.3390\/cancers16203459.","DOI":"10.3390\/cancers16203459"},{"key":"7873_CR99","doi-asserted-by":"publisher","unstructured":"D O, et al. Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition - PubMed. Oncoimmunology. 1. 08\/1\/2012. https:\/\/doi.org\/10.4161\/onci.20365.","DOI":"10.4161\/onci.20365"},{"key":"7873_CR100","doi-asserted-by":"publisher","unstructured":"Z W, et al. TSH-TSHR axis promotes tumor immune evasion - PubMed. J Immunother Cancer. 2022 Jan;10. https:\/\/doi.org\/10.1136\/jitc-2021-004049.","DOI":"10.1136\/jitc-2021-004049"},{"key":"7873_CR101","doi-asserted-by":"publisher","unstructured":"M H, et al. Suppressor of cytokine signaling 1 inhibits the maturation of dendritic cells involving the nuclear factor kappa B signaling pathway in the glioma microenvironment - PubMed. Clin Exp Immunol. 2020 Oct;202. https:\/\/doi.org\/10.1111\/cei.13476.","DOI":"10.1111\/cei.13476"},{"key":"7873_CR102","doi-asserted-by":"publisher","unstructured":"Ew R, et al. Critical Role for CD103(+)\/CD141(+) Dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in Melanoma - PubMed. Cancer Cell. 30. 08\/8\/2016. https:\/\/doi.org\/10.1016\/j.ccell.2016.06.003.","DOI":"10.1016\/j.ccell.2016.06.003"},{"key":"7873_CR103","doi-asserted-by":"publisher","unstructured":"G W, J W, C N, Y Z, P W. Neutrophils: new critical regulators of glioma - PubMed. Front Immunol. 13. 07\/4\/2022. https:\/\/doi.org\/10.3389\/fimmu.2022.927233.","DOI":"10.3389\/fimmu.2022.927233"},{"key":"7873_CR104","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41591-023-02673-1","volume":"30","author":"R Sankowski","year":"2024","unstructured":"Sankowski R, et al. Multiomic spatial landscape of innate immune cells at human central nervous system borders. Nat Med. 2024;30:186\u201398. https:\/\/doi.org\/10.1038\/s41591-023-02673-1.","journal-title":"Nat Med"},{"key":"7873_CR105","doi-asserted-by":"publisher","unstructured":"Friedrich M, et al. Dysfunctional dendritic cells limit antigen-specific T cell response in glioma. Neuro-Oncology. 2023\/02\/14;25. https:\/\/doi.org\/10.1093\/neuonc\/noac138.","DOI":"10.1093\/neuonc\/noac138"},{"key":"7873_CR106","doi-asserted-by":"publisher","unstructured":"Gp T, et al. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+\/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner - PubMed. Front Immunol. 13. 01\/4\/2023. https:\/\/doi.org\/10.3389\/fimmu.2022.993444.","DOI":"10.3389\/fimmu.2022.993444"},{"key":"7873_CR107","doi-asserted-by":"publisher","unstructured":"Ja B-K, et al. The Conventional Dendritic cell 1 Subset primes CD8+ T cells and traffics tumor antigen to drive antitumor immunity in the brain - PubMed. Cancer Immunol Res. 11. 01\/3\/2023. https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0098.","DOI":"10.1158\/2326-6066.CIR-22-0098"},{"key":"7873_CR108","doi-asserted-by":"publisher","unstructured":"D K, et al. Direct oHSV infection Induces DC maturation and a tumor therapeutic response - PubMed. Viruses. 17. 08\/19\/2025. https:\/\/doi.org\/10.3390\/v17081134.","DOI":"10.3390\/v17081134"},{"key":"7873_CR109","doi-asserted-by":"publisher","unstructured":"Z Z, X H, E W, Y H, R Y. Identification and characterization of B220+\/B220- subpopulations in murine Gr1+CD11b+ cells during tumorigenesis - PubMed. Oncoimmunology. 10. 04\/14\/2021. https:\/\/doi.org\/10.1080\/2162402X.2021.1912472.","DOI":"10.1080\/2162402X.2021.1912472"},{"key":"7873_CR110","doi-asserted-by":"publisher","unstructured":"W F, X H, L D, W H. Roles of STAT3 in the pathogenesis and treatment of glioblastoma - PubMed. Front Cell Dev Biol. 11. 02\/27\/2023. https:\/\/doi.org\/10.3389\/fcell.2023.1098482.","DOI":"10.3389\/fcell.2023.1098482"},{"key":"7873_CR111","doi-asserted-by":"publisher","unstructured":"M B, L C, M R, M S. A two-step human culture system replicates intestinal monocyte maturation cascade: conversion of tissue-like inflammatory monocytes into macrophages - PubMed. Eur J Immunol. 2020 Nov;50. https:\/\/doi.org\/10.1002\/eji.202048555.","DOI":"10.1002\/eji.202048555"},{"key":"7873_CR112","doi-asserted-by":"publisher","unstructured":"Q F, et al. Hypoxia Inducible factors\u2019 signaling in pediatric high-grade gliomas: role, modelization and innovative targeted approaches - PubMed. Cancers. 12. 04\/15\/2020. https:\/\/doi.org\/10.3390\/cancers12040979.","DOI":"10.3390\/cancers12040979"},{"key":"7873_CR113","doi-asserted-by":"publisher","unstructured":"A O, Wka Y, N M. Molecular mechanisms of treatment resistance in glioblastoma - PubMed. Int J Mol Sci. 22. 12\/31\/2020. https:\/\/doi.org\/10.3390\/ijms22010351.","DOI":"10.3390\/ijms22010351"},{"key":"7873_CR114","doi-asserted-by":"publisher","unstructured":"Jm S, et al. Spatial transcriptomics in glioblastoma: is knowing the right zip code the key to the next therapeutic breakthrough? - PubMed. Front Oncol. 13. 10\/17\/2023. https:\/\/doi.org\/10.3389\/fonc.2023.1266397.","DOI":"10.3389\/fonc.2023.1266397"},{"key":"7873_CR115","doi-asserted-by":"publisher","unstructured":"R R, et al. Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment - PubMed. JCI Insight. 9. 08\/22\/2024. https:\/\/doi.org\/10.1172\/jci.insight.179854.","DOI":"10.1172\/jci.insight.179854"},{"key":"7873_CR116","doi-asserted-by":"publisher","unstructured":"Ji E, et al. Glioblastoma microenvironment and invasiveness: new insights and therapeutic targets - PubMed. Int J Mol Sci. 24. 04\/11\/2023. https:\/\/doi.org\/10.3390\/ijms24087047.","DOI":"10.3390\/ijms24087047"},{"key":"7873_CR117","doi-asserted-by":"publisher","unstructured":"S S, et al. Glioblastoma at the crossroads: current understanding and future therapeutic horizons - PubMed. Signal Transduct Targeted Ther. 10. 07\/9\/2025. https:\/\/doi.org\/10.1038\/s41392-025-02299-4.","DOI":"10.1038\/s41392-025-02299-4"},{"key":"7873_CR118","doi-asserted-by":"publisher","unstructured":"J J, et al. Mitochondrial NIX promotes tumor survival in the hypoxic niche of glioblastoma - PubMed. Cancer Res. 79. 10\/15\/2019. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0198.","DOI":"10.1158\/0008-5472.CAN-19-0198"},{"key":"7873_CR119","doi-asserted-by":"publisher","unstructured":"W Z, et al. Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy - PubMed. NPJ Precis Oncol. 9. 05\/2\/2025. https:\/\/doi.org\/10.1038\/s41698-025-00920-x.","DOI":"10.1038\/s41698-025-00920-x"},{"key":"7873_CR120","doi-asserted-by":"publisher","unstructured":"Y L, et al. Interactions between glioblastoma and myeloid cells - PubMed. Front Cell Dev Biol. 13. 06\/24\/2025. https:\/\/doi.org\/10.3389\/fcell.2025.1632122.","DOI":"10.3389\/fcell.2025.1632122"},{"key":"7873_CR121","doi-asserted-by":"publisher","unstructured":"V D, G J, S M, Sh C, Py P. Analyzing one cell at a TIME: analysis of myeloid cell contributions in the tumor immune microenvironment - PubMed. Front Immunol. 11. 09\/2\/2020. https:\/\/doi.org\/10.3389\/fimmu.2020.01842.","DOI":"10.3389\/fimmu.2020.01842"},{"key":"7873_CR122","doi-asserted-by":"publisher","unstructured":"Shard C, et al. Novel GABAAR antagonists target networked gene hubs at the leading edge in high-grade gliomas. Neuro-Oncology. 2025. https:\/\/doi.org\/10.1093\/neuonc\/noaf143.","DOI":"10.1093\/neuonc\/noaf143"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07873-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07873-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07873-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:22:48Z","timestamp":1774617768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07873-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7873"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07873-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript is a review article and does not report on or involve the use of any animal or human data or tissue.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain data from any individual person.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no financial or non-financial competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"432"}}